Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma.

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)

Lenalidomide recently was shown to have clinical activity in patients with human immunodeficiency virus-associated Kaposi sarcoma. Immunomodulatory imine drugs thus provide another tool in the treatment of this challenging neoplasm. See related article by Reid et al., p. 2646.

Keyphrases

human immunodeficiency virus
hepatitis c virus
multiple myeloma
antiretroviral therapy
newly diagnosed
stem cell transplantation
hiv infected
hiv aids
hiv positive
low grade
drug induced
low dose
combination therapy